Medicare Enrolled
Dr. James Mackey, MD
Medical Oncology · Southlake, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mackey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mackey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mackey
Dr. James Mackey is a medical oncology specialist in Southlake, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mackey performed 567 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mackey received a total of $311,683 from 93 pharmaceutical and/or device companies across 1073 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mackey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 567 Medicare services
$311,683 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗567
Medicare services
Bottom 38% in TX for medical oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
231 | $75 | $217 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
89 | $44 | $258 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
87 | $108 | $315 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $31 | $183 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $99 | $321 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $62 | $203 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $102 | $317 |
| New patient office visit, complex (60-74 min) | 17 | $142 | $460 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$311,683
Total received (2018-2024)
Avg $44,526/year across 7 years
Top 6% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,073
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$428
2023
$8,113
2022
$9,094
2021
$99,968
2020
$26,647
2019
$120,163
2018
$47,269
Payments by company (2024)
ABBVIE INC.
$148
SEAGEN INC.
$99
PFIZER INC.
$34
Merck Sharp & Dohme LLC
$31
Bayer Healthcare Pharmaceuticals Inc.
$24
GlaxoSmithKline, LLC.
$23
Janssen Biotech, Inc.
$21
Coherus Biosciences Inc.
$17
Novocure Inc.
$16
Tempus AI, Inc
$14
Top 3 companies account for 65.8% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$256,443
Celgene Corporation
$19,688
Heron Therapeutics, Inc.
$12,856
Gilead Sciences, Inc.
$5,310
Pharmacosmos Therapeutics Inc.
$3,392
Amgen Inc.
$1,283
E.R. Squibb & Sons, L.L.C.
$1,093
Novartis Pharmaceuticals Corporation
$1,057
AstraZeneca Pharmaceuticals LP
$779
Seagen Inc.
$651
PFIZER INC.
$647
GENZYME CORPORATION
$547
Genentech USA, Inc.
$523
Lilly USA, LLC
$506
Janssen Biotech, Inc.
$439
Pharmacyclics LLC, An AbbVie Company
$412
Astellas Pharma US Inc
$341
Merck Sharp & Dohme Corporation
$334
Rigel Pharmaceuticals, Inc.
$322
Takeda Pharmaceuticals U.S.A., Inc.
$307
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Incyte Corporation
$279
Boehringer Ingelheim Pharmaceuticals, Inc.
$248
GlaxoSmithKline, LLC.
$205
Dendreon Pharmaceuticals LLC
$197
Merck Sharp & Dohme LLC
$177
ABBVIE INC.
$148
Ipsen Biopharmaceuticals, Inc
$147
Regeneron Healthcare Solutions, Inc.
$142
Seattle Genetics, Inc.
$135
AVEO Pharmaceuticals, Inc.
$132
Bayer HealthCare Pharmaceuticals Inc.
$125
Exelixis Inc.
$121
SANOFI-AVENTIS U.S. LLC
$120
BeiGene USA, Inc.
$114
Verastem, Inc.
$112
TESARO, Inc.
$109
EISAI INC.
$101
SEAGEN INC.
$99
Taiho Oncology, Inc.
$87
Dova Pharmaceuticals
$86
AbbVie, Inc.
$84
Teva Pharmaceuticals USA, Inc.
$79
JAZZ PHARMACEUTICALS INC.
$74
Janssen Pharmaceuticals, Inc
$60
CTI BioPharma Corp.
$56
Eisai Inc.
$52
ASD Specialty Healthcare, LLC
$52
Kite Pharma, Inc.
$47
ARRAY BIOPHARMA INC
$46
Lexicon Pharmaceuticals, Inc.
$45
MEDIVATION FIELD SOLUTIONS LLC
$45
Octapharma USA, Inc.
$42
Janssen Scientific Affairs, LLC
$42
Puma Biotechnology, Inc.
$37
Helsinn Therapeutics (U.S.), Inc.
$37
Alexion Pharmaceuticals, Inc.
$36
Coherus Biosciences Inc.
$35
Sirtex Medical Inc
$33
Mirati Therapeutics, Inc.
$31
SOBI, INC
$29
Array BioPharma Inc.
$28
INSYS Therapeutics Inc
$28
Mylan Institutional Inc.
$28
G1 Therapeutics, Inc.
$27
Progenics Pharmaceuticals, Inc.
$27
Adaptive Biotechnologies Corporation
$25
Deciphera Pharmaceuticals Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$24
Myriad Genetic Laboratories, Inc.
$22
Epizyme, Inc.,
$21
Pharmacyclics LLC, an AbbVie Company
$20
Foundation Medicine, Inc.
$20
Ferring Pharmaceuticals Inc.
$20
Aveo Pharmaceuticals, Inc.
$20
MorphoSys, US Inc.
$20
Spectrum Pharmaceuticals Inc.
$19
Sobi, Inc
$18
Sun Pharmaceutical Industries Inc.
$18
Fortovia Therapeutics, Inc.
$17
Kyowa Kirin, Inc.
$16
Jazz Pharmaceuticals Inc.
$16
EMD Serono, Inc.
$16
Blue Earth Diagnostics Limited
$16
Novocure Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Karyopharm Therapeutics Inc.
$15
Sysmex Inostics Inc
$15
AMAG Pharmaceuticals, Inc.
$14
Tempus AI, Inc
$14
Novo Nordisk Inc
$13
Tactile Systems Technology Inc
$11
Clovis Oncology, Inc.
$3
Top 3 companies account for 92.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · Axumin · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRILINTA · BRUKINSA · Braftovi · CABOMETYX · CALQUENCE · CERDELGA · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELOCTATE · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FERAHEME · FIRMAGON · FLEXITOUCH · FOTIVDA · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Idhifa · Imbruvica · JADENU · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kovaltry · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · Monoferric · NINLARO · NIVESTYM · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · ONUREG · OPDIVO · Optune Lua (NovoTTF-200T) · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROLARIS · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · PYLARIFY · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TAXOTERE · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tresiba · Trodelvy · Truxima · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
88
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHLAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mackey is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mackey experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mackey performed 231 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mackey receive payments from pharmaceutical companies?
Yes. Dr. Mackey received a total of $311,683 from 93 companies across 1,073 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mackey's costs compare to other medical oncologists in Southlake?
Dr. Mackey's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mackey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Southlake
Browse medical oncologists in Southlake ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Heron Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Heron Therapeutics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology